• A M Gülmezoglu and G J Hofmeyr.
• Special Department of Research, Development and Research Training in Human Reproduction, UNDP/UNFPA/WHO/World Bank, World Health Organisation, Geneva 27, Switzerland, CH-1211. gulmezoglum@who.ch
• Cochrane Db Syst Rev. 2000 Jan 1; 2003 (2): CD000109CD000109.

BackgroundIt has been suggested that oestrogens may improve fetal growth due to an increase in nutritional supply to the fetus from greater uterine blood flow.ObjectivesThe objective of this review was to assess the effects of hormone administration for suspected impaired fetal growth and perinatal outcome.Search StrategyWe searched the Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register. Date of last search: 22 December 1999.Selection CriteriaAcceptably controlled trials of hormone administration for suspected impaired fetal growth which report fetal, perinatal or maternal outcomes.Data Collection And AnalysisEligibility and trial quality were assessed.Main ResultsNo studies were included since none of the potentially relevant trials reported clinical outcomes.Reviewer's ConclusionsThere is not enough evidence to evaluate the clinical use of hormone administration for suspected impaired fetal growth.

7 keywords...

hide…